
Tuan H. Nguyen
Examiner (ID: 4878)
| Most Active Art Unit | 2813 |
| Art Unit(s) | 2813, 3991, 3992, 1104 |
| Total Applications | 1968 |
| Issued Applications | 1723 |
| Pending Applications | 53 |
| Abandoned Applications | 192 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18449546
[patent_doc_number] => 20230190822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLS
[patent_app_type] => utility
[patent_app_number] => 17/923431
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923431
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923431 | METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLS | May 4, 2021 | Pending |
Array
(
[id] => 17185220
[patent_doc_number] => 20210332105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/237498
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237498 | Compositions and methods of treating cancer with chimeric antigen receptors | Apr 21, 2021 | Issued |
Array
(
[id] => 18364831
[patent_doc_number] => 20230146422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => ANIMAL MODEL FOR STUDYING CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/996901
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996901 | ANIMAL MODEL FOR STUDYING CANCER IMMUNOTHERAPY | Apr 20, 2021 | Pending |
Array
(
[id] => 17258480
[patent_doc_number] => 20210371465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHOD OF USING A TLR9 ANTAGONIST AS AN ANTI-INFLAMMATORY AND ANTI-FIBROTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/213299
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/213299 | METHOD OF USING A TLR9 ANTAGONIST AS AN ANTI-INFLAMMATORY AND ANTI-FIBROTIC AGENT | Mar 25, 2021 | Abandoned |
Array
(
[id] => 18676782
[patent_doc_number] => 20230314412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => Neuronal diencephalon stem cells, preparation and uses for treatment and prevention of hormonal disorders and other diseases
[patent_app_type] => utility
[patent_app_number] => 17/913403
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913403 | Neuronal diencephalon stem cells, preparation and uses for treatment and prevention of hormonal disorders and other diseases | Mar 18, 2021 | Pending |
Array
(
[id] => 16916237
[patent_doc_number] => 20210189329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => PRODUCTION OF EXTRACELLULAR VESICLES FROM STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/194972
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194972 | Production of extracellular vesicles from stem cells | Mar 7, 2021 | Issued |
Array
(
[id] => 17853138
[patent_doc_number] => 20220283180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => TDP-43 IN DEGENERATIVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/189967
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189967
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189967 | TDP-43 IN DEGENERATIVE DISEASE | Mar 1, 2021 | Pending |
Array
(
[id] => 17297846
[patent_doc_number] => 20210393685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => ANTI-CD33 AND NKG2D LIGAND CHIMERAS FOR TREATMENT OF MYELOID MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 17/182422
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182422 | ANTI-CD33 AND NKG2D LIGAND CHIMERAS FOR TREATMENT OF MYELOID MALIGNANCIES | Feb 22, 2021 | Abandoned |
Array
(
[id] => 17022600
[patent_doc_number] => 20210246471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => MODIFICATION OF HEAVY CHAIN FIBROIN IN BOMBYX MORI
[patent_app_type] => utility
[patent_app_number] => 17/172818
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172818 | MODIFICATION OF HEAVY CHAIN FIBROIN IN BOMBYX MORI | Feb 9, 2021 | Abandoned |
Array
(
[id] => 20077555
[patent_doc_number] => 12351605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Optically controllable FGFR stimulation using wireless controlled cellular lighting system
[patent_app_type] => utility
[patent_app_number] => 17/152220
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 75
[patent_no_of_words] => 16945
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152220 | Optically controllable FGFR stimulation using wireless controlled cellular lighting system | Jan 18, 2021 | Issued |
Array
(
[id] => 16805919
[patent_doc_number] => 20210128472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE
[patent_app_type] => utility
[patent_app_number] => 17/247661
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17247661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/247661 | EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE | Dec 17, 2020 | Abandoned |
Array
(
[id] => 16750168
[patent_doc_number] => 20210102177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/119484
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119484 | DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS | Dec 10, 2020 | Pending |
Array
(
[id] => 16728112
[patent_doc_number] => 20210095259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => COMPOSITION AND METHOD FOR INDUCTION OF PLURIPOTENT STEM CELL
[patent_app_type] => utility
[patent_app_number] => 17/118555
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118555 | COMPOSITION AND METHOD FOR INDUCTION OF PLURIPOTENT STEM CELL | Dec 9, 2020 | Abandoned |
Array
(
[id] => 17657381
[patent_doc_number] => 20220177846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => GENOME-EDITED INDUCED PLURIPOTENT STEM CELLS, AND CELLS DERIVED THEREFROM, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/116332
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116332 | Genome-edited induced pluripotent stem cells, and cells derived therefrom, and uses thereof | Dec 8, 2020 | Issued |
Array
(
[id] => 18108044
[patent_doc_number] => 20230000924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY
[patent_app_type] => utility
[patent_app_number] => 17/781265
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781265 | COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY | Dec 1, 2020 | Pending |
Array
(
[id] => 18692906
[patent_doc_number] => 20230323263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => SPECIAL CULTURE APPARATUS FOR 3D BIOLOGICAL TISSUE, AND METHOD FOR PREPARING BLOCK-SHAPED CULTURED MEAT
[patent_app_type] => utility
[patent_app_number] => 18/022872
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022872
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022872 | SPECIAL CULTURE APPARATUS FOR 3D BIOLOGICAL TISSUE, AND METHOD FOR PREPARING BLOCK-SHAPED CULTURED MEAT | Nov 26, 2020 | Pending |
Array
(
[id] => 16901100
[patent_doc_number] => 20210180016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => PLATELETS LOADED WITH mRNA
[patent_app_type] => utility
[patent_app_number] => 17/104528
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104528 | PLATELETS LOADED WITH mRNA | Nov 24, 2020 | Abandoned |
Array
(
[id] => 16946673
[patent_doc_number] => 20210205364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => LONG LIVED ENGINEERED T CELLS FOR ADOPTIVE CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/099402
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099402 | LONG LIVED ENGINEERED T CELLS FOR ADOPTIVE CELL THERAPY | Nov 15, 2020 | Pending |
Array
(
[id] => 18167974
[patent_doc_number] => 20230034582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => CELL POPULATION AND METHOD OF OBTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/788285
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788285 | CELL POPULATION AND METHOD OF OBTAINING THE SAME | Oct 7, 2020 | Pending |
Array
(
[id] => 16570935
[patent_doc_number] => 20210009941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOSITION THAT CONTAINS POLYLYSINE ANALOG AND PROMOTES CELL GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/036476
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/036476 | COMPOSITION THAT CONTAINS POLYLYSINE ANALOG AND PROMOTES CELL GROWTH | Sep 28, 2020 | Abandoned |